SEC Form 3 · accession 0001438327-26-000003
Veraxa Biotech AG - Post de-SPAC · VRXA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Warren Hosseinion
Director
Period of report
Jun 9, 2026
Accepted (ET)
Jun 9, 2026 · 9:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002079109
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | holding | — | — | — | 700,000 | D |
Table II — derivative securities
No Table II lines on this filing.